We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
- Authors
Jahangirian, Ehsan; Jamal, Ghadir A.; Nouroozi, MohammadReza; Mohammadpour, Alemeh
- Abstract
Since 2019, the world was involved with SARS-CoV-2 and consequently, with the announcement by the World Health Organization that COVID-19 was a pandemic, scientific were an effort to obtain the best approach to combat this global dilemma. The best way to prevent the pandemic from spreading further is to use a vaccine against COVID-19. Here, we report the design of a recombinant multi-epitope vaccine against the four proteins spike or crown (S), membrane (M), nucleocapsid (N), and envelope (E) of SARS-CoV-2 using immunoinformatics tools. We evaluated the most antigenic epitopes that bind to HLA class 1 subtypes, along with HLA class 2, as well as B cell epitopes. Beta-defensin 3 and PADRE sequence were used as adjuvants in the structure of the vaccine. KK, GPGPG, and AAY linkers were used to fuse the selected epitopes. The nucleotide sequence was cloned into pET26b(+) vector using restriction enzymes XhoI and NdeI, and HisTag sequence was considered in the C-terminal of the construct. The results showed that the proposed candidate vaccine is a 70.87 kDa protein with high antigenicity and immunogenicity as well as non-allergenic and non-toxic. A total of 95% of the selected epitopes have conservancy with similar sequences. Molecular docking showed a strong binding between the vaccine structure and tool-like receptor (TLR) 7/8. The docking, molecular dynamics, and MM/PBSA analysis showed that the vaccine established a stable interaction with both structures of TLR7 and TLR8. Simulation of immune stimulation by this vaccine showed that it evokes immune responses related to humoral and cellular immunity.
- Subjects
WORLD Health Organization; COVID-19; SARS-CoV-2; COVID-19 pandemic; NUCLEOTIDE sequence; VACCINES; MOLECULAR dynamics
- Publication
Immunogenetics, 2021, Vol 73, Issue 6, p459
- ISSN
0093-7711
- Publication type
Article
- DOI
10.1007/s00251-021-01228-3